Noncoding RNA may promote Alzheimer's disease

Researchers show that the small RNA 38A spurs cells to manufacture Var IV, a splice variant of a key neuronal protein, and potentially promote Alzheimer's disease. In this image, Var IV (green) is prevalent in cells that make extra 38A (left) but rare in control cells (right). Credit: Massone, S., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201011053.

Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease (AD) or other types of neurodegeneration. The study appears in the May 30 issue of The Journal of Cell Biology.

Like a movie with an alternate ending, a protein can come in more than one version. Although scientists have identified numerous proteins and RNAs that influence alternative splicing, they haven't deciphered how cells fine-tune the process to produce specific protein versions. Four years ago, researchers identified a set of 30 small, noncoding RNAs that they suspected help regulate gene expression.

Italian researchers have now determined the function of one of the RNA snippets, known as 38A, that hails from a noncoding part of the gene that encodes the protein KCNIP4. KCNIP4 helps ensure that neurons fire impulses in a characteristic slow, repeating pattern. The researchers found that 38A spurs cells to produce an alternative splice variant of KCNIP4, Var IV, that disrupts this current, potentially leading to neurodegeneration.

KCNIP4 normally interacts with , the enzyme complex that helps generate (Abeta), a protein that accumulates in the brains of AD patients. But Var IV can't make the connection, possibly disturbing Abeta processing. Supporting that notion, the researchers found that levels of 38A were more than 10 times higher in from AD patients than in controls and that 38A hiked output of the more dangerous Abeta isoform Abeta 1-42.

More information: Massone, S., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201011053

Related Stories

APP -- Good, bad or both?

Oct 18, 2009

New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development. So ...

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.